IL2 and metastatic melanoma: Previous therapy directed at LMD and/or metastatic melanoma is allowed, including IT therapy (washout 7 d), radiation (washout 7 d) and systemic biologic therapy (CTLA4 and/or PD, IL-2, interferon, washout 14 d).